- Users of weight-loss jabs like Mounjaro, Wegovy, and Ozempic could invalidate their travel and health insurance due to confusion over declaring them as medication.
- A survey revealed that over a quarter of UK adults were unaware that these drugs count as medication for a pre-existing condition when purchasing cover.
- Many people incorrectly perceive weight-loss jabs as a lifestyle or cosmetic tool rather than a medical treatment, which can lead to non-disclosure.
- Failure to declare pre-existing medical conditions, including the use of GLP-1 agonists, can void insurance policies, potentially leaving individuals out of pocket.
- Insurers and industry bodies emphasise the critical importance of disclosing all prescribed medications and medical conditions to ensure valid insurance cover.
IN FULL
